Position in DGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$31,368
+$2,363 QoQ
Shares Held
148
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#930
of 1,090 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Millstone Evans Group, LLC holds $2,395,454 across 10 Diagnostics & Research names. DGX ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,267 | $1,136,583 | |
| 2 | WAT |
Waters Corp /De/
|
2,388 | $895,595 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
933 | $180,274 | |
| 4 | DHR |
Danaher Corp /De/
|
438 | $83,430 | |
| 5 | RVTY |
Revvity, Inc.
|
340 | $37,828 | |
| 6 | DGX |
Quest Diagnostics Inc
This page
|
148 | $31,368 | |
| 7 | A |
Agilent Technologies, Inc.
|
132 | $17,533 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
10 | $5,295 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,368 | 148 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $29,005 | 148 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $25,682 | 148 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $28,205 | 148 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $26,585 | 148 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,041 | 148 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $22,327 | 148 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||